|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 25 Massachusetts Avenue, NW |
Address2 | Suite 320 |
| City | Washington |
State | DC |
Zip Code | 20001 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 1650-12
|
||||||||
|
6. House ID# 317150000
|
||||||||
| TYPE OF REPORT | 8. Year | 2022 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Lorraine Jordan |
Date | 10/20/2022 10:51:37 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Black Maternal Health Momnibus Act of 2021 (H.R. 959/S.346) - Issues pertaining to CRNA practice in maternal health care
Bipartisan Safer Communities Act (S. 2938) - Issues pertaining to CRNA scope of practice
Expanding Access to Mental Health Training Act (S. 4461) - Issues pertaining to CRNA scope of practice
Advancing Telehealth Beyond COVID-19 Act of 2021 (H.R. 4040) - Issues pertaining to CRNA scope of practice
CONNECT Act of 2022 (H.R. 8391) - Issues pertaining to CRNA scope of practice
Improving Access to Workers Compensation for Injured Federal Workers Act of 2022 (H.R. 6087) - Issues pertaining to nurse practitioner and PA certification of federal worker disability claims
Future Advancement of Academic Nursing Act (H.R. 851/S. 246) - Issues pertaining to nursing education
Nominations to HHS agency councils: AHRQ National Advisory Council for Healthcare Research and Quality; HRSA National Advisory Council on Nurse Education and Practice
HHS Initiative to Strengthen Primary Health Care - Issues pertaining to removing regulatory barriers that limit access to care
Surprise Billing
CRNA Scope of Practice
CRNA Reimbursement
Rural Healthcare
Extension of CMS waivers beyond public health emergency
Nursing Workforce
Opioid Epidemic/Opioid-sparing treatments/MATs
Provider nondiscrimination
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA), Agency for Healthcare Research & Quality (AHRQ)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Ralph |
Kohl |
|
|
|
Randi |
Gold |
|
|
|
Romy |
Gelb-Zimmer |
|
|
|
Matt |
Thackston |
|
|
|
JP |
Mason |
|
|
|
Catharine |
Harris |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
Nomination to VA Veterans Rural Health Advisory Committee
Reimbursement for VA CRNAs
Full Practice Authority for VA CRNAs
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Ralph |
Kohl |
|
|
|
Randi |
Gold |
|
|
|
Romy |
Gelb-Zimmer |
|
|
|
Matt |
Thackston |
|
|
|
JP |
Mason |
|
|
|
Catharine |
Harris |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Improving Care and Access to Nurses Act of 2022 (H.R. 8812) - Issues pertaining to regulatory relief for advanced practice registered nurses
CMS Behavioral Health Strategy - Issues pertaining to CRNA Scope of Practice, reimbursement, and innovative models to decrease opioid use
Medicare Advantage Request for Information - Issues pertaining to provider nondiscrimination, network adequacy, reducing regulatory barriers, and health information technology
Hospital Outpatient and ASC Prospective Payment Rule (87 Fed. Reg. 44502) - Issues pertaining to reimbursement for non-opioid treatments for pain, CRNA practice, and reducing regulatory burdens
Clinical Laboratory Improvement Amendments of 1998 rule - Issues pertaining to the definition of mid-level practitioners in labs
Physician Fee Schedule Proposed Rule (87 Fed. Reg. 45860) - Issues pertaining to CRNA practice and reimbursement
Conditions of Participation (CoPs) for Rural Emergency Hospitals (REH) and Critical Access Hospital CoP (87 Fed. Reg. 40350) - Issues pertaining to CRNA & APRN practice
Nomination to MACRA Wave 1 Comprehensive Reevaluation Clinician Expert Workgroup on Routine Cataract Removal with Intraocular Lens (IOL) Implantation
Extending/Making permanent certain temporary waivers put in place during the Public Health Emergency
Medicare Reimbursement
CRNA Scope of Practice
Support for the Medicare Advantage Program
Rural Healthcare issues
Medicare teaching rules
Provider nondiscrimination
Medicare Local Coverage Determination process
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Ralph |
Kohl |
|
|
|
Romy |
Gelb-Zimmer |
|
|
|
Randi |
Gold |
|
|
|
Matt |
Thackston |
|
|
|
JP |
Mason |
|
|
|
Catharine |
Harris |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Labor, Health and Human Services, Education, and Related Agencies Appropriations Act of 2023 (H.R. 8295/S. 4659) - Issues pertaining to increased funding for Title VIII Nursing Workforce Development Programs
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Ralph |
Kohl |
|
|
|
JP |
Mason |
|
|
|
Matthew |
Thackston |
|
|
|
Romy |
Gelb Zimmer |
|
|
|
Randi |
Gold |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Nurse Corp Tax Parity Act of 2022 (S. 3505)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Ralph |
Kohl |
|
|
|
JP |
Mason |
|
|
|
Matthew |
Thackston |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |